Corrigendum to "Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension" [Eur. J. Pharmacol. 943 (2023) 175558].

Autor: Abdulkareem AO; Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India; Animal Physiology Unit, Department of Zoology, University of Ilorin, Ilorin, Nigeria., Tiwari P; Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India., Lone ZR; Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India., Iqbal H; Department of Molecular Bio-Prospection, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India., Gupta S; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India; Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, 226031, India., Jha RK; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India; Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, 226031, India., Chanda D; Department of Molecular Bio-Prospection, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India., Jagavelu K; Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India., Hanif K; Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India. Electronic address: k_hanif@cdri.res.in.
Jazyk: angličtina
Zdroj: European journal of pharmacology [Eur J Pharmacol] 2023 Jul 05; Vol. 950, pp. 175750. Date of Electronic Publication: 2023 May 03.
DOI: 10.1016/j.ejphar.2023.175750
Databáze: MEDLINE